Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Dijon
Clinical trial register · France

Clinical Trials in Dijon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Bordeaux 40 Caen 36 Angers 31 Dijon 30 Avignon 27
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier Universitaire Dijon102 AstraZeneca36 UNICANCER30 Centre Georges Francois Leclerc25 Hospices Civils de Lyon23 Clear sponsor filter
Site location
Bordeaux40 Caen36 Angers31 Dijon30 Avignon27
All 80 locations
Target enrolment
to

Trials with a site in Dijon

30 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
NCT07241273Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Cancers, Oropharyngeal Carcinoma, Head and Neck
UNICANCER
Not applicable
128
Brest, Caen, Dijon, Le Havre, Lille, Montpellier, Paris, Rouen
2026-09
Not yet open
UNICANCER
Phase 2/3
160
Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille
2026-07
Recruiting
UNICANCER
Phase 2/3
196
Bordeaux, Clichy, Dijon, Marseille, Montpellier, Nantes, Paris, Poitiers
2025-11-14
Recruiting
UNICANCER
Phase 3
700
Brest, Dijon, Paris, Saint-Etienne, Villejuif
2025-04-10
Recruiting
UNICANCER
Phase 2
73
Amiens, Angers, Avignon, Besançon, Cholet, Dijon, Lyon, Montpellier
2025-03-21
Recruiting
UNICANCER
Phase 2
220
Amiens, Avignon, Bayonne, Besançon, Bordeaux, Caen, Dijon, La Roche-sur-Yon
2025-03-11
Recruiting
UNICANCER
Phase 2
198
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Limoges, Lyon
2025-01-27
Recruiting
UNICANCER
Phase 2
354
Amiens, Avignon, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Dijon, Levallois-Perret
2024-12-27
Recruiting
UNICANCER
Phase 3
500
Angers, Bordeaux, Brest, Caen, Créteil, Dijon, Grenoble, Lyon
2024-09-12
Recruiting
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
NCT06333314Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma, Adrenocortical Carcinoma, Neuroendocrine Carcinoma
DrugDostarlimab
UNICANCER
Phase 2
120
Angers, Avignon, Besançon, Brest, Caen, Clermont-Ferrand, Créteil, Dijon
2024-07-23
Recruiting
UNICANCER
Phase 2
420
Saint-Denis, Avignon, Dijon, Lille, Marseille, Nice, Nîmes, Paris
2024-04-03
Recruiting
Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
NCT05800275Leptomeningeal Metastasis, Leptomeningeal Disease, HER2-positive Metastatic Breast Cancer
DrugsTucatinib·Trastuzumab·Capecitabine
UNICANCER
Phase 2
30
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Montpellier, Nice, Reims
2023-12-18
Active, closed
UNICANCER
Phase 2
100
Aix-en-Provence, Avignon, Bayonne, Caen, Clermont-Ferrand, Créteil, Dijon, Lille
2023-03-24
Active, closed
UNICANCER
Phase 2
10
Bobigny, Bordeaux, Boulogne-Billancourt, Caen, Créteil, Dijon, Lyon, Marseille
2022-09-05
Recruiting
TARGETed Therapy Drug MONITOring in DIGestive Oncology
NCT05443087Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma, GIST
UNICANCER
Not applicable
330
Amiens, Auxerre, Avignon, Bayeux, Clermont-Ferrand, Clichy, Dijon, Évreux
2022-08-29
Active, closed
UNICANCER
Phase 2
53
Angers, Bordeaux, Caen, Dijon, Le Mans, Lyon, Montpellier, Nice
2021-12-17
Recruiting
UNICANCER
Phase 3
102
Avignon, Besançon, Bordeaux, Caen, Carcassonne, Clermont-Ferrand, Dijon, Le Havre
2021-12-01
Active, closed
UNICANCER
Phase 3
490
Albi, Angers, Bordeau, Dijon, Le Puy-en-Velay, Lille, Montpellier, Nice
2020-01-09
Active, closed
UNICANCER
Not applicable
200
Angers, Avignon, Caen, Chalon-sur-Saône, Cholet, Clermont-Ferrand, Dijon, Lyon
2019-10-23
Active, closed
UNICANCER
Phase 2
79
Bordeaux, Clermont-Ferrand, Dijon, Lille, Montpellier, Mougins, Nice, Paris
2018-12-14
Active, closed
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
NCT03438552Local Recurrence of Malignant Tumor of Prostate
UNICANCER
Not applicable
57
Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Montpellier, Paris, Rennes
2018-10-18
Active, closed
UNICANCER
Not applicable
81
Angers, Bordeaux, Caen, Dijon, Grenoble, Lille, Limoges, Lorient
2018-04-19
Recruiting
UNICANCER
Observational
75,000
Angers, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Lille, Lyon
2017-10-02
Active, closed
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776Triple-Negative Breast Neoplasm
UNICANCER
Not applicable
149
Clermont-Ferrand, Dijon, Lyon, Marseille, Nantes, Rennes, Strasbourg, Vandœuvre-lès-Nancy
2017-04-14
Active, closed
UNICANCER
Not applicable
1,265
Amiens, Angers, Besançon, Bordeaux, Clermont-Ferrand, Créteil, Dijon, Le Havre
2016-09
Recruiting
UNICANCER
Observational
42,000
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille
2014-07
Active, closed
UNICANCER
Phase 2
1,460
Angers, Avignon, Bordeaux, Caen, Clermont-Ferrand, Dijon, La Roche-sur-Yon, Lille
2014-04-07
Active, closed
UNICANCER
Phase 3
700
Amiens, Besançon, Bordeaux, Brest, Créteil, Dijon, La Roche-sur-Yon, Lille
2011-07
Active, closed
UNICANCER
Phase 3
415
Amiens, Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble
2011-04-26
Active, closed
UNICANCER
Phase 3
318
Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble
2007-03
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 October 2026. https://priyalifescience.com/clinical-trials-france/city/dijon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Dijon that also match the filters currently applied.

How many clinical trials are recruiting in Dijon?

14 of the 30 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 2 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dijon), 30 studies
PhaseStudiesRecruitingShare
Phase 212740%
Not applicable7123.3%
Phase 37323.3%
Observational226.7%
Phase 2/3216.7%

Most active sponsors

Lead sponsors with the most studies (Dijon)
Lead sponsorStudiesRecruiting
UNICANCER3014
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.